Show simple item record

dc.contributor.authorRye, Morten Beck
dc.contributor.authorKrossa, Sebastian
dc.contributor.authorHall, Martina
dc.contributor.authorvan Mourik, Casper
dc.contributor.authorBathen, Tone Frost
dc.contributor.authorDrabløs, Finn
dc.contributor.authorTessem, May-Britt
dc.contributor.authorBertilsson, Helena
dc.date.accessioned2023-02-14T11:41:31Z
dc.date.available2023-02-14T11:41:31Z
dc.date.created2022-09-15T13:08:34Z
dc.date.issued2022
dc.identifier.citationiScience. 2022, 25 (6), .en_US
dc.identifier.issn2589-0042
dc.identifier.urihttps://hdl.handle.net/11250/3050660
dc.description.abstractHigh secretion of the metabolites citrate and spermine is a unique hallmark for normal prostate epithelial cells, and is reduced in aggressive prostate cancer. However, the identity of the genes controlling this biological process is mostly unknown. In this study, we have created a gene signature of 150 genes connected to citrate and spermine secretion in the prostate. We have computationally integrated metabolic measurements with multiple transcriptomics datasets from the public domain, including 3826 tissue samples from prostate and prostate cancer. The accuracy of the signature is validated by its unique enrichment in prostate samples and prostate epithelial tissue compartments. The signature highlights genes AZGP1, ANPEP and metallothioneins with zinc-binding properties not previously studied in the prostate, and the expression of these genes are reduced in more aggressive cancer lesions. However, the absence of signature enrichment in common prostate model systems can make it challenging to study these genes mechanistically.en_US
dc.language.isoengen_US
dc.publisherCell Pressen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleThe genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systemsen_US
dc.title.alternativeThe genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systemsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume25en_US
dc.source.journaliScienceen_US
dc.source.issue6en_US
dc.identifier.doi10.1016/j.isci.2022.104451
dc.identifier.cristin2052039
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal